Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
BRAF	673	broad.mit.edu	37	7	140453136	140453136	+	Missense_Mutation	SNP	A	A	T	rs121913377|rs121913227		THCA-TCGA-EL-A3D6-Tumor-SM-2HRMG	THCA-TCGA-EL-A3D6-Normal-SM-2HRML	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3D6-Tumor-SM-2HRMG	THCA-TCGA-EL-A3D6-Normal-SM-2HRML	g.chr7:140453136A>T	ENST00000288602.6	-	15	1859	c.1799T>A	c.(1798-1800)gTg>gAg	p.V600E		NM_004333.4	NP_004324.2	P15056	BRAF_HUMAN	v-raf murine sarcoma viral oncogene homolog B	600	Protein kinase.	NA	V -> D (in a melanoma cell line; requires 2 nucleotide substitutions).|V -> E (in sarcoma, colorectal adenocarcinoma, metastatic melanoma, ovarian serous carcinoma, pilocytic astrocytoma; somatic mutation; most common mutation; constitutive and elevated kinase activity; efficiently induces cell transformation; suppression of mutation in melanoma causes growth arrest and promotes apoptosis).		activation of MAPKK activity|anti-apoptosis|nerve growth factor receptor signaling pathway|organ morphogenesis|positive regulation of peptidyl-serine phosphorylation|small GTPase mediated signal transduction|synaptic transmission	cytosol|nucleus|plasma membrane	ATP binding|metal ion binding	p.V600E(15453)|p.V600K(252)|p.V600R(44)|p.V600D(16)|p.V600A(12)|p.V600_K601>E(12)|p.V600G(11)|p.T599_R603>I(2)|p.V600Q(2)|p.V600_S605>EK(1)|p.V600_S605>DV(1)|p.V600_S605>D(1)|p.T599_V600insDFGLAT(1)	SLC45A3/BRAF(2)|AGTRAP/BRAF(2)|FAM131B_ENST00000443739/BRAF(7)|AKAP9_ENST00000356239/BRAF(10)|KIAA1549/BRAF(703)|FCHSD1/BRAF(2)	NS(588)|adrenal_gland(3)|autonomic_ganglia(3)|biliary_tract(29)|bone(7)|breast(21)|central_nervous_system(99)|cervix(6)|endometrium(33)|eye(72)|gastrointestinal_tract_(site_indeterminate)(2)|genital_tract(4)|haematopoietic_and_lymphoid_tissue(436)|kidney(3)|large_intestine(6953)|liver(17)|lung(192)|oesophagus(4)|ovary(275)|pancreas(15)|pituitary(1)|prostate(25)|salivary_gland(1)|skin(6285)|small_intestine(12)|soft_tissue(40)|stomach(11)|testis(7)|thyroid(12220)|upper_aerodigestive_tract(13)|urinary_tract(3)	27380	Melanoma(164;0.00956)				Sorafenib(DB00398)	TCGAGATTTCACTGTAGCTAG	0.368	V600D(K029AX_SKIN)|V600D(WM115_SKIN)|V600D(WM2664_SKIN)|V600E(8505C_THYROID)|V600E(A101D_SKIN)|V600E(A2058_SKIN)|V600E(A375_SKIN)|V600E(A673_BONE)|V600E(AM38_CENTRAL_NERVOUS_SYSTEM)|V600E(BCPAP_THYROID)|V600E(BHT101_THYROID)|V600E(BT474_BREAST)|V600E(C32_SKIN)|V600E(CL34_LARGE_INTESTINE)|V600E(COLO205_LARGE_INTESTINE)|V600E(COLO679_SKIN)|V600E(COLO741_SKIN)|V600E(COLO783_SKIN)|V600E(COLO800_SKIN)|V600E(COLO818_SKIN)|V600E(COLO829_SKIN)|V600E(COLO849_SKIN)|V600E(DBTRG05MG_CENTRAL_NERVOUS_SYSTEM)|V600E(DU4475_BREAST)|V600E(ES2_OVARY)|V600E(G361_SKIN)|V600E(GCT_SOFT_TISSUE)|V600E(HS294T_SKIN)|V600E(HS695T_SKIN)|V600E(HS939T_SKIN)|V600E(IGR1_SKIN)|V600E(IGR37_SKIN)|V600E(IGR39_SKIN)|V600E(K029AX_SKIN)|V600E(KG1C_CENTRAL_NERVOUS_SYSTEM)|V600E(LOXIMVI_SKIN)|V600E(MALME3M_SKIN)|V600E(MELHO_SKIN)|V600E(OUMS23_LARGE_INTESTINE)|V600E(RKO_LARGE_INTESTINE)|V600E(RPMI7951_SKIN)|V600E(RVH421_SKIN)|V600E(SH4_SKIN)|V600E(SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|V600E(SKHEP1_LIVER)|V600E(SKMEL24_SKIN)|V600E(SKMEL28_SKIN)|V600E(SKMEL5_SKIN)|V600E(SW1417_LARGE_INTESTINE)|V600E(UACC257_SKIN)|V600E(UACC62_SKIN)|V600E(WM793_SKIN)|V600E(WM88_SKIN)|V600E(WM983B_SKIN)	61	"""Mis, T, O"""	"""AKAP9, KIAA1549"""	"""melanoma, colorectal, papillary thyroid, borderline ov, Non small-cell lung cancer (NSCLC), cholangiocarcinoma, pilocytic astrocytoma"""		Cardio-facio-cutaneous syndrome		Cardiofaciocutaneous syndrome					NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Colon(40;35 892 2973 5743 27438)		Dom	yes		7	7q34	673	v-raf murine sarcoma viral oncogene homolog B1	yes	E	15808	Substitution - Missense(15790)|Complex - deletion inframe(17)|Insertion - In frame(1)	thyroid(7476)|skin(3822)|large_intestine(3288)|NS(360)|haematopoietic_and_lymphoid_tissue(336)|ovary(211)|lung(58)|eye(57)|central_nervous_system(53)|soft_tissue(30)|biliary_tract(18)|liver(17)|prostate(13)|breast(10)|upper_aerodigestive_tract(9)|endometrium(8)|pancreas(8)|testis(7)|small_intestine(7)|genital_tract(4)|stomach(4)|bone(3)|autonomic_ganglia(2)|oesophagus(2)|urinary_tract(2)|adrenal_gland(2)|pituitary(1)	NA	NA	NA	NA	NA						112	104	107	NA	NA	NA	NA	7		NA		NA						NA			NA				140453136		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	CFC, CFCS	ENSG00000157764	HGNC:1097	NM_004333	Approved	uc003vwc.4	NA	A4D1T4|B6HY61|B6HY62|B6HY63|B6HY64|B6HY65|B6HY66|Q13878|Q3MIN6|Q9UDP8|Q9Y6T3	ENST00000288602.6	37	CCDS5863.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	A|A	24.0|24.0	4.486113|4.486113	0.84854|0.84854	.|.	.|.	ENSG00000157764|ENSG00000157764	ENST00000288602|ENST00000496384	D|.	0.81739|.	-1.53|.	5.65|5.65	5.65|5.65	0.86999|0.86999	Serine-threonine/tyrosine-protein kinase (1);Protein kinase-like domain (1);Protein kinase, catalytic domain (1);|.	0.000000|.	0.85682|.	D|.	0.000000|.	T|.	0.61565|.	0.2357|.	L|L	0.42245|0.42245	1.32|1.32	0.80722|0.80722	D|D	1|1	D|.	0.55385|.	0.971|.	D|.	0.66351|.	0.943|.	T|.	0.58160|.	-0.7685|.	10|.	0.87932|.	D|.	0|.	.|.	15.9326|15.9326	0.79675|0.79675	1.0:0.0:0.0:0.0|1.0:0.0:0.0:0.0	.|.	600|.	P15056|.	BRAF_HUMAN|.	E|R	600|208	ENSP00000288602:V600E|.	ENSP00000288602:V600E|.	V|X	-|-	2|1	0|0	BRAF|BRAF	140099605|140099605	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.998000|0.998000	0.95712|0.95712	9.197000|9.197000	0.94985|0.94985	2.169000|2.169000	0.68431|0.68431	0.529000|0.529000	0.55759|0.55759	GTG|TGA	BRAF-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000348886.1	87.85329	KEEP		-	93.584595	0.268908	32	87	---	---	---	---	1	0.9876371	6	15	0	109	40	103	0	109	2	1	1	264	391	0	674	40	103	0	109	2	TP
FAM110B	90362	broad.mit.edu	37	8	59058923	59058923	+	Missense_Mutation	SNP	C	C	T			THCA-TCGA-EL-A3D6-Tumor-SM-2HRMG	THCA-TCGA-EL-A3D6-Normal-SM-2HRML	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3D6-Tumor-SM-2HRMG	THCA-TCGA-EL-A3D6-Normal-SM-2HRML	g.chr8:59058923C>T	ENST00000361488.3	+	5	1014	c.134C>T	c.(133-135)cCc>cTc	p.P45L	FAM110B_ENST00000520369.1_Intron	NM_147189.2	NP_671722.1	Q8TC76	F110B_HUMAN	family with sequence similarity 110, member B	45		NA				microtubule organizing center|mitochondrion|nucleus				breast(1)|endometrium(3)|kidney(1)|large_intestine(10)|lung(9)|skin(2)	26		all_epithelial(80;0.025)|all_lung(136;0.0274)|Lung NSC(129;0.0355)				GAGCCCAACCCCAAGAGGCTC	0.667		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0			NA	NA	NA	NA	NA						34	37	36	NA	NA	NA	NA	8		NA		NA						NA			NA				59058923		2203	4300	6503	SO:0001583	missense				HGNC:28587	NM_147189	Approved	uc003xtj.1	NA	Q5BM08|Q9Y4K2	ENST00000361488.3	37	CCDS6170.1	.	.	.	.	.	.	.	.	.	.	C	19.04	3.750181	0.69533	.	.	ENSG00000169122	ENST00000361488	T	0.47869	0.83	5.0	5.0	0.66597	.	0.000000	0.85682	D	0.000000	T	0.62380	0.2423	M	0.61703	1.905	0.80722	D	1	P	0.50066	0.931	P	0.57204	0.815	T	0.61598	-0.7030	9	.	.	.	-19.1696	18.2903	0.90127	0.0:1.0:0.0:0.0	.	45	Q8TC76	F110B_HUMAN	L	45	ENSP00000355204:P45L	.	P	+	2	0	FAM110B	59221477	1.000000	0.71417	1.000000	0.80357	0.948000	0.59901	4.659000	0.61504	2.312000	0.78011	0.313000	0.20887	CCC	FAM110B-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000378095.2	16.93061	KEEP		+	21.983531	0.176471	9	42	---	---	---	---	1	0.7429913	7	5	0	40	12	46	0	40	2	0	0	0	0	0	0	12	46	0	40	2	TP
CA13	377677	broad.mit.edu	37	8	86193478	86193478	+	Missense_Mutation	SNP	T	T	G			THCA-TCGA-EL-A3D6-Tumor-SM-2HRMG	THCA-TCGA-EL-A3D6-Normal-SM-2HRML	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3D6-Tumor-SM-2HRMG	THCA-TCGA-EL-A3D6-Normal-SM-2HRML	g.chr8:86193478T>G	ENST00000321764.3	+	7	991	c.689T>G	c.(688-690)cTc>cGc	p.L230R		NM_198584.2	NP_940986.1	Q8N1Q1	CAH13_HUMAN	carbonic anhydrase XIII	230		NA			one-carbon metabolic process		carbonate dehydratase activity|zinc ion binding			large_intestine(1)|lung(6)	7						TTTCGCAGTCTCCTGTGCACA	0.458		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0			NA	NA	NA	NA	NA						143	169	160	NA	NA	NA	NA	8		NA		NA						NA			NA				86193478		2203	4300	6503	SO:0001583	missense				HGNC:14914	NM_198584	Approved	uc003ydg.2	NA		ENST00000321764.3	37	CCDS6236.1	.	.	.	.	.	.	.	.	.	.	T	16.17	3.046088	0.55110	.	.	ENSG00000185015	ENST00000321764	T	0.68181	-0.31	5.32	5.32	0.75619	Carbonic anhydrase, alpha-class, catalytic domain (4);	0.056894	0.64402	D	0.000001	D	0.86364	0.5915	H	0.94345	3.525	0.80722	D	1	D	0.89917	1.0	D	0.97110	1.0	D	0.90154	0.4223	10	0.87932	D	0	-18.0628	14.5548	0.68094	0.0:0.0:0.0:1.0	.	230	Q8N1Q1	CAH13_HUMAN	R	230	ENSP00000318912:L230R	ENSP00000318912:L230R	L	+	2	0	CA13	86380730	1.000000	0.71417	0.690000	0.30148	0.181000	0.23173	6.123000	0.71614	2.139000	0.66308	0.459000	0.35465	CTC	CA13-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000381066.1	37.890876	KEEP		+	79.226397	0.109489	30	244	---	---	---	---	1	0.9007797	9	25	0	327	37	295	0	327	2	0	0	0	0	0	0	37	295	0	327	2	TP
NCBP1	4686	broad.mit.edu	37	9	100409798	100409798	+	Silent	SNP	C	C	T			THCA-TCGA-EL-A3D6-Tumor-SM-2HRMG	THCA-TCGA-EL-A3D6-Normal-SM-2HRML	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3D6-Tumor-SM-2HRMG	THCA-TCGA-EL-A3D6-Normal-SM-2HRML	g.chr9:100409798C>T	ENST00000375147.3	+	7	892	c.636C>T	c.(634-636)ccC>ccT	p.P212P		NM_002486.4	NP_002477.1	Q09161	NCBP1_HUMAN	nuclear cap binding protein subunit 1, 80kDa	212	MIF4G.	NA			gene silencing by RNA|histone mRNA metabolic process|mRNA 3'-end processing|mRNA capping|mRNA cleavage|mRNA export from nucleus|ncRNA metabolic process|nuclear-transcribed mRNA catabolic process, nonsense-mediated decay|positive regulation of mRNA 3'-end processing|positive regulation of viral transcription|regulation of translational initiation|spliceosomal snRNP assembly|termination of RNA polymerase II transcription|transcription elongation from RNA polymerase II promoter|viral reproduction	cytosol|mRNA cap binding complex|nucleoplasm|ribonucleoprotein complex	protein binding|RNA cap binding			NS(1)|central_nervous_system(3)|endometrium(2)|kidney(2)|large_intestine(7)|lung(4)	19		Acute lymphoblastic leukemia(62;0.158)				CTCATGTACCCATGTTACAGG	0.368		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Ovarian(36;879 898 2893 44212 50307)					NA		NA				0			NA	NA	NA	NA	NA						127	115	119	NA	NA	NA	NA	9		NA		NA						NA			NA				100409798		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000136937	HGNC:7658	NM_002486	Approved	uc004axq.3	NA	B2R718|Q59G76|Q5T1V0|Q5T7X2	ENST00000375147.3	37	CCDS6728.1																																																																																			NCBP1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000053337.1	-11.849904	KEEP		+	6.677837	0.0375	3	77	---	---	---	---	1	0.511342	2	29	0	99	5	97	0	99	2	0	0	0	0	0	0	5	97	0	99	2	TP
JMJD1C	221037	broad.mit.edu	37	10	64973913	64973913	+	Nonsense_Mutation	SNP	T	T	A			THCA-TCGA-EL-A3D6-Tumor-SM-2HRMG	THCA-TCGA-EL-A3D6-Normal-SM-2HRML	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3D6-Tumor-SM-2HRMG	THCA-TCGA-EL-A3D6-Normal-SM-2HRML	g.chr10:64973913T>A	ENST00000399262.2	-	8	2232	c.2014A>T	c.(2014-2016)Aga>Tga	p.R672*	JMJD1C_ENST00000402544.1_Nonsense_Mutation_p.R453*|JMJD1C_ENST00000542921.1_Nonsense_Mutation_p.R490*|JMJD1C_ENST00000489372.2_5'Flank|JMJD1C_ENST00000399251.1_Nonsense_Mutation_p.R453*	NM_032776.1	NP_116165.1	Q15652	JHD2C_HUMAN	jumonji domain containing 1C	672		NA			blood coagulation|regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleoplasm	histone demethylase activity (H3-K9 specific)|metal ion binding|oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen|thyroid hormone receptor binding			breast(2)|central_nervous_system(2)|cervix(1)|endometrium(8)|kidney(8)|large_intestine(9)|lung(27)|ovary(6)|prostate(4)|skin(4)|stomach(3)|upper_aerodigestive_tract(3)	77	Prostate(12;0.0119)|all_hematologic(501;0.191)					TTTGCCAATCTTCTTTCACCA	0.388		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0			NA	NA	NA	NA	NA						145	134	137	NA	NA	NA	NA	10		NA		NA						NA			NA				64973913		1882	4117	5999	SO:0001587	stop_gained			ENSG00000171988	HGNC:12313	NM_004241	Approved	uc001jmn.3	NA	Q5SQZ8|Q5SQZ9|Q5SR00|Q7Z3E7|Q8N3U0|Q96KB9|Q9P2G7	ENST00000399262.2	37	CCDS41532.1	.	.	.	.	.	.	.	.	.	.	T	45	11.916321	0.99617	.	.	ENSG00000171988	ENST00000399262;ENST00000402544;ENST00000399251;ENST00000542921	.	.	.	6.11	2.15	0.27550	.	0.161513	0.53938	D	0.000042	.	.	.	.	.	.	0.80722	A	1	.	.	.	.	.	.	.	.	.	.	0.02654	T	1	-20.5233	13.5488	0.61719	0.0:0.0:0.3527:0.6473	.	.	.	.	X	672;453;453;490	.	ENSP00000382195:R453X	R	-	1	2	JMJD1C	64643919	1.000000	0.71417	1.000000	0.80357	0.985000	0.73830	2.908000	0.48750	1.095000	0.41419	0.533000	0.62120	AGA	JMJD1C-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000048249.2	40.015313	KEEP		-	51.101109	0.181034	21	95	---	---	---	---	1	0.543768	2	7	0	151	25	106	0	151	2	1	1	74	759	0	812	25	106	0	151	2	TP
CD44	960	broad.mit.edu	37	11	35226166	35226166	+	Missense_Mutation	SNP	C	C	A			THCA-TCGA-EL-A3D6-Tumor-SM-2HRMG	THCA-TCGA-EL-A3D6-Normal-SM-2HRML	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3D6-Tumor-SM-2HRMG	THCA-TCGA-EL-A3D6-Normal-SM-2HRML	g.chr11:35226166C>A	ENST00000428726.2	+	10	1384	c.1261C>A	c.(1261-1263)Cat>Aat	p.H421N	CD44_ENST00000437706.2_Missense_Mutation_p.H421N|CD44_ENST00000433892.2_Intron|CD44_ENST00000434472.2_Intron|CD44_ENST00000263398.6_Intron|CD44_ENST00000449691.2_Intron|CD44_ENST00000352818.4_Intron|CD44_ENST00000360158.4_Intron|CD44_ENST00000433354.2_Missense_Mutation_p.H422N|CD44_ENST00000415148.2_Missense_Mutation_p.H378N|CD44_ENST00000526669.2_Intron|CD44_ENST00000278386.6_Intron	NM_000610.3	NP_000601.3	P16070	CD44_HUMAN	CD44 molecule (Indian blood group)	421	Stem.	NA			cell-cell adhesion|cell-matrix adhesion|interferon-gamma-mediated signaling pathway|negative regulation of apoptosis|negative regulation of DNA damage response, signal transduction by p53 class mediator|positive regulation of ERK1 and ERK2 cascade|positive regulation of peptidyl-serine phosphorylation|positive regulation of peptidyl-tyrosine phosphorylation	cell surface|Golgi apparatus|integral to plasma membrane	collagen binding|hyaluronic acid binding|receptor activity			cervix(1)|endometrium(1)|kidney(2)|large_intestine(4)|lung(13)|pancreas(1)|skin(1)	23	all_cancers(35;0.212)|all_lung(20;0.0874)|all_epithelial(35;0.112)	all_hematologic(20;0.107)	STAD - Stomach adenocarcinoma(6;0.00731)		Hyaluronidase(DB00070)	AGAAGACTCCCATTCGACAAC	0.438		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0			NA	NA	NA	NA	NA						144	123	130	NA	NA	NA	NA	11		NA		NA						NA			NA				35226166		2202	4298	6500	SO:0001583	missense			ENSG00000026508	HGNC:1681	NM_000610	Approved	uc001mvu.3	NA	A5YRN9|D3DR12|D3DR13|P22511|Q04858|Q13419|Q13957|Q13958|Q13959|Q13960|Q13961|Q13967|Q13968|Q13980|Q15861|Q16064|Q16065|Q16066|Q16208|Q16522|Q86T72|Q86Z27|Q8N694|Q92493|Q96J24|Q9H5A5|Q9UC28|Q9UC29|Q9UC30|Q9UCB0|Q9UJ36	ENST00000428726.2	37	CCDS7897.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	C|C	8.156|8.156	0.788411|0.788411	0.16258|0.16258	.|.	.|.	ENSG00000026508|ENSG00000026508	ENST00000415148;ENST00000433354;ENST00000437706;ENST00000428726;ENST00000531110;ENST00000528672|ENST00000526553	T;T;T;T;T;T|.	0.20200|.	2.09;2.09;2.09;2.09;2.09;2.09|.	5.15|5.15	2.2|2.2	0.27929|0.27929	.|.	1.142740|.	0.06318|.	N|.	0.703976|.	T|T	0.44456|0.44456	0.1294|0.1294	M|M	0.65975|0.65975	2.015|2.015	0.18873|0.18873	N|N	0.999986|0.999986	B;B|.	0.29432|.	0.231;0.244|.	B;B|.	0.33042|.	0.157;0.075|.	T|T	0.33675|0.33675	-0.9859|-0.9859	10|5	0.31617|.	T|.	0.26|.	-29.7237|-29.7237	5.7475|5.7475	0.18128|0.18128	0.0:0.6608:0.1609:0.1783|0.0:0.6608:0.1609:0.1783	.|.	378;421|.	P16070-4;P16070|.	.;CD44_HUMAN|.	N|Q	378;422;421;421;133;73|74	ENSP00000389830:H378N;ENSP00000414567:H422N;ENSP00000403990:H421N;ENSP00000398632:H421N;ENSP00000436549:H133N;ENSP00000431860:H73N|.	ENSP00000389830:H378N|.	H|P	+|+	1|2	0|0	CD44|CD44	35182742|35182742	0.686000|0.686000	0.27661|0.27661	0.070000|0.070000	0.20053|0.20053	0.001000|0.001000	0.01503|0.01503	0.160000|0.160000	0.16462|0.16462	0.382000|0.382000	0.24878|0.24878	-0.136000|-0.136000	0.14681|0.14681	CAT|CCA	CD44-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000388927.1	-18.603917	KEEP		+	7.055943	0.036364	4	106	---	---	---	---	1	0.9996183	352	132	0	106	4	112	0	106	2	0	0	0	0	0	0	4	112	0	106	2	TP
AHNAK	79026	broad.mit.edu	37	11	62284755	62284755	+	Missense_Mutation	SNP	T	T	C			THCA-TCGA-EL-A3D6-Tumor-SM-2HRMG	THCA-TCGA-EL-A3D6-Normal-SM-2HRML	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3D6-Tumor-SM-2HRMG	THCA-TCGA-EL-A3D6-Normal-SM-2HRML	g.chr11:62284755T>C	ENST00000378024.4	-	5	17408	c.17134A>G	c.(17134-17136)Atc>Gtc	p.I5712V	AHNAK_ENST00000257247.7_Intron|AHNAK_ENST00000530124.1_Intron|AHNAK_ENST00000525875.1_5'UTR	NM_001620.1	NP_001611.1	Q09666	AHNK_HUMAN	AHNAK nucleoprotein	5712		NA			nervous system development	nucleus	protein binding			NS(3)|autonomic_ganglia(1)|breast(10)|central_nervous_system(5)|endometrium(17)|haematopoietic_and_lymphoid_tissue(2)|kidney(33)|large_intestine(40)|liver(1)|lung(108)|ovary(13)|pancreas(4)|prostate(5)|skin(16)|stomach(2)|upper_aerodigestive_tract(2)|urinary_tract(6)	268		Melanoma(852;0.155)				GGCATTTTGATCTTGGACTTT	0.483		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0			NA	NA	NA	NA	NA						78	81	80	NA	NA	NA	NA	11		NA		NA						NA			NA				62284755		2201	4299	6500	SO:0001583	missense			ENSG00000124942	HGNC:347	NM_024060	Approved	uc001ntl.3	NA		ENST00000378024.4	37	CCDS31584.1	.	.	.	.	.	.	.	.	.	.	T	12.58	1.979556	0.34942	.	.	ENSG00000124942	ENST00000378024	T	0.01059	5.39	4.77	3.62	0.41486	.	.	.	.	.	T	0.03390	0.0098	L	0.46741	1.465	0.34604	D	0.716871	P	0.46784	0.884	P	0.62491	0.903	T	0.54180	-0.8332	9	0.28530	T	0.3	.	10.611	0.45421	0.1438:0.0:0.0:0.8562	.	5712	Q09666	AHNK_HUMAN	V	5712	ENSP00000367263:I5712V	ENSP00000367263:I5712V	I	-	1	0	AHNAK	62041331	0.086000	0.21541	0.988000	0.46212	0.876000	0.50452	0.372000	0.20467	0.661000	0.30985	0.448000	0.29417	ATC	AHNAK-005	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000395572.1	-32.709091	KEEP		-	6.630926	0.019737	3	149	---	---	---	---	1	0.9990189	25	1202	0	159	3	167	0	159	2	0	0	0	0	0	0	3	167	0	159	2	TP
LRRK2	120892	broad.mit.edu	37	12	40734124	40734124	+	Silent	SNP	C	C	A			THCA-TCGA-EL-A3D6-Tumor-SM-2HRMG	THCA-TCGA-EL-A3D6-Normal-SM-2HRML	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3D6-Tumor-SM-2HRMG	THCA-TCGA-EL-A3D6-Normal-SM-2HRML	g.chr12:40734124C>A	ENST00000298910.7	+	41	6035	c.5977C>A	c.(5977-5979)Cga>Aga	p.R1993R		NM_198578.3	NP_940980.3	Q5S007	LRRK2_HUMAN	leucine-rich repeat kinase 2	1993	Protein kinase.	NA			activation of MAPKK activity|determination of adult lifespan|exploration behavior|intracellular distribution of mitochondria|negative regulation of branching morphogenesis of a nerve|negative regulation of dendritic spine morphogenesis|negative regulation of neuroblast proliferation|negative regulation of neuron maturation|neuromuscular junction development|neuron death|peptidyl-serine phosphorylation|positive regulation of autophagy|positive regulation of dopamine receptor signaling pathway|positive regulation of programmed cell death|positive regulation of proteasomal ubiquitin-dependent protein catabolic process|positive regulation of protein phosphorylation|positive regulation of protein ubiquitination|protein autophosphorylation|regulation of kidney size|regulation of locomotion|regulation of membrane potential|response to oxidative stress|small GTPase mediated signal transduction|tangential migration from the subventricular zone to the olfactory bulb	external side of mitochondrial outer membrane	ATP binding|GTP binding|GTP-dependent protein kinase activity|GTPase activator activity|MAP kinase kinase activity|protein homodimerization activity|tubulin binding			NS(3)|biliary_tract(1)|breast(6)|central_nervous_system(2)|cervix(1)|endometrium(15)|haematopoietic_and_lymphoid_tissue(1)|kidney(23)|large_intestine(31)|lung(55)|ovary(15)|pancreas(2)|prostate(4)|skin(4)|stomach(9)|upper_aerodigestive_tract(7)|urinary_tract(2)	181	all_cancers(12;0.00108)|Breast(8;0.218)	Lung NSC(34;0.0942)|all_lung(34;0.11)				GATTATATACCGAGACCTGAA	0.398		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0			NA	NA	NA	NA	NA						213	195	201	NA	NA	NA	NA	12		NA		NA						NA			NA				40734124		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000188906	HGNC:18618	XM_058513	Approved	uc001rmg.4	NA	A6NJU2|Q6ZS50|Q8NCX9	ENST00000298910.7	37	CCDS31774.1																																																																																			LRRK2-004	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000277179.1	-54.909238	KEEP		+	7.312163	0.016949	4	232	---	---	---	---	1	0.5251861	2	109	0	282	4	293	0	282	2	0	0	0	0	0	0	4	293	0	282	2	TP
LONP2	83752	broad.mit.edu	37	16	48381506	48381506	+	Missense_Mutation	SNP	G	G	A			THCA-TCGA-EL-A3D6-Tumor-SM-2HRMG	THCA-TCGA-EL-A3D6-Normal-SM-2HRML	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3D6-Tumor-SM-2HRMG	THCA-TCGA-EL-A3D6-Normal-SM-2HRML	g.chr16:48381506G>A	ENST00000285737.4	+	13	2120	c.2027G>A	c.(2026-2028)cGa>cAa	p.R676Q	LONP2_ENST00000535754.1_Missense_Mutation_p.R632Q	NM_031490.2	NP_113678.2	Q86WA8	LONP2_HUMAN	lon peptidase 2, peroxisomal	676		NA			misfolded or incompletely synthesized protein catabolic process|protein targeting to peroxisome|signal peptide processing	nucleoid|peroxisomal matrix	ATP binding|ATP-dependent peptidase activity|enzyme binding|sequence-specific DNA binding|serine-type endopeptidase activity			breast(2)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(7)|lung(13)|prostate(1)|skin(1)|upper_aerodigestive_tract(1)	31						GAGGCGAGTCGAATGGATGGC	0.557		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0			NA	NA	NA	NA	NA						129	128	128	NA	NA	NA	NA	16		NA		NA						NA			NA				48381506		2200	4300	6500	SO:0001583	missense			ENSG00000102910	HGNC:20598	NM_031490	Approved	uc002efi.1	NA	Q0D2H6|Q8N3B9|Q8NCE9|Q96K43	ENST00000285737.4	37	CCDS10734.1	.	.	.	.	.	.	.	.	.	.	G	35	5.453446	0.96223	.	.	ENSG00000102910	ENST00000285737;ENST00000544734;ENST00000535754	T;T	0.29655	1.56;1.56	6.06	6.06	0.98353	Ribosomal protein S5 domain 2-type fold (1);Peptidase S16, Lon C-terminal (1);	0.000000	0.85682	D	0.000000	T	0.47414	0.1444	L	0.46157	1.445	0.80722	D	1	D;D	0.89917	1.0;1.0	D;D	0.65323	0.934;0.934	T	0.07578	-1.0765	10	0.12766	T	0.61	-11.7093	20.6208	0.99490	0.0:0.0:1.0:0.0	.	632;676	B7ZKL7;Q86WA8	.;LONP2_HUMAN	Q	676;405;632	ENSP00000285737:R676Q;ENSP00000445426:R632Q	ENSP00000285737:R676Q	R	+	2	0	LONP2	46939007	1.000000	0.71417	0.995000	0.50966	0.931000	0.56810	7.856000	0.86956	2.882000	0.98803	0.655000	0.94253	CGA	LONP2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000256839.2	-16.693004	KEEP		+	7.254158	0.038462	4	100	---	---	---	---	1	0.962904	8	127	0	135	5	108	0	135	2	0	0	0	0	0	0	5	108	0	135	2	TP
TP53	7157	broad.mit.edu	37	17	7572986	7572986	+	Nonsense_Mutation	SNP	G	G	A			THCA-TCGA-EL-A3D6-Tumor-SM-2HRMG	THCA-TCGA-EL-A3D6-Normal-SM-2HRML	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3D6-Tumor-SM-2HRMG	THCA-TCGA-EL-A3D6-Normal-SM-2HRML	g.chr17:7572986G>A	ENST00000269305.4	-	11	1312	c.1123C>T	c.(1123-1125)Cag>Tag	p.Q375*	TP53_ENST00000455263.2_3'UTR|TP53_ENST00000413465.2_Intron|TP53_ENST00000359597.4_Intron|TP53_ENST00000445888.2_Nonsense_Mutation_p.Q375*|TP53_ENST00000420246.2_3'UTR	NM_000546.5|NM_001126112.2|NM_001126118.1|NM_001276760.1|NM_001276761.1	NP_000537.3|NP_001119584.1|NP_001119590.1|NP_001263689.1|NP_001263690.1	P04637	P53_HUMAN	tumor protein p53	375	Basic (repression of DNA-binding).|Interaction with CARM1.	NA			activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray	cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork	ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding	p.0?(8)|p.?(1)|p.Q375*(1)		NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79)	24185		all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081)		GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174)		GAGGTAGACTGACCCTTTTTG	0.527		111	"""Mis, N, F"""		"""breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types"""	"""breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types"""		Other conserved DNA damage response genes	Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of	HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(47;798 1329 9957 10801)	yes	Rec	yes	Li-Fraumeni syndrome	17	17p13	7157	tumor protein p53		"""L, E, M, O"""	10	Whole gene deletion(8)|Substitution - Nonsense(1)|Unknown(1)	bone(4)|haematopoietic_and_lymphoid_tissue(2)|central_nervous_system(2)|urinary_tract(1)|stomach(1)	NA	NA	NA	NA	NA						193	173	180	NA	NA	NA	NA	17		NA		NA						NA			NA				7572986		2203	4300	6503	SO:0001587	stop_gained	Familial Cancer Database	Familial Osteogenic Sarcoma;LFS, SBLA syndrome (Sarcoma Breast Leukemia Adrenal cancer), incl.: Cancer with In Vitro Radioresistence, Familial, Li-Fraumeni-like s.;BRCAX;Familial Adrenocortical Carcinoma;	ENSG00000141510	HGNC:11998	NM_000546	Approved	uc002gij.3	NA	Q15086|Q15087|Q15088|Q16535|Q16807|Q16808|Q16809|Q16810|Q16811|Q16848|Q2XN98|Q3LRW1|Q3LRW2|Q3LRW3|Q3LRW4|Q3LRW5|Q86UG1|Q8J016|Q99659|Q9BTM4|Q9HAQ8|Q9NP68|Q9NPJ2|Q9NZD0|Q9UBI2|Q9UQ61	ENST00000269305.4	37	CCDS11118.1	.	.	.	.	.	.	.	.	.	.	G	21.0	4.079412	0.76528	.	.	ENSG00000141510	ENST00000269305;ENST00000445888;ENST00000396473;ENST00000419024	.	.	.	5.31	3.18	0.36537	.	0.952987	0.08806	N	0.891079	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	0.05721	T	0.95	-7.9939	7.7108	0.28677	0.0:0.1941:0.6294:0.1765	.	.	.	.	X	375;375;364;26	.	ENSP00000269305:Q375X	Q	-	1	0	TP53	7513711	0.963000	0.33076	0.841000	0.33234	0.615000	0.37417	1.786000	0.38694	1.427000	0.47276	0.561000	0.74099	CAG	TP53-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000367397.1	-23.084329	KEEP		-	10.572478	0.040541	6	142	---	---	---	---	1	0.9472127	7	108	0	171	7	151	0	171	2	0	0	0	0	0	0	7	151	0	171	2	TP
HDAC8	55869	broad.mit.edu	37	X	71681859	71681859	+	Missense_Mutation	SNP	G	G	A			THCA-TCGA-EL-A3D6-Tumor-SM-2HRMG	THCA-TCGA-EL-A3D6-Normal-SM-2HRML	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3D6-Tumor-SM-2HRMG	THCA-TCGA-EL-A3D6-Normal-SM-2HRML	g.chrX:71681859G>A	ENST00000373573.3	-	9	1341	c.1000C>T	c.(1000-1002)Cat>Tat	p.H334Y	HDAC8_ENST00000429103.2_Missense_Mutation_p.H139Y|HDAC8_ENST00000373583.1_Intron|HDAC8_ENST00000373589.4_Missense_Mutation_p.H243Y	NM_018486.2	NP_060956.1	Q9BY41	HDAC8_HUMAN	histone deacetylase 8	334		NA			chromatin assembly or disassembly|negative regulation of transcription from RNA polymerase II promoter|transcription, DNA-dependent	cytoplasm|histone deacetylase complex|nuclear chromosome	histone deacetylase activity (H3-K16 specific)|metal ion binding|NAD-dependent histone deacetylase activity (H3-K14 specific)|NAD-dependent histone deacetylase activity (H3-K9 specific)|NAD-dependent histone deacetylase activity (H4-K16 specific)|transcription factor binding			breast(3)|cervix(1)|endometrium(1)|lung(4)|prostate(1)	10	Renal(35;0.156)				Vorinostat(DB02546)	CTTACCTCATGATCTGGGATC	0.483		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0			NA	NA	NA	NA	NA						119	94	102	NA	NA	NA	NA	X		NA		NA						NA			NA				71681859		2203	4300	6503	SO:0001583	missense			ENSG00000147099	HGNC:13315	NM_018486	Approved	uc004eau.3	NA	A6NET3|A8MQ62|Q86VC8|Q9NP76|Q9NYH4	ENST00000373573.3	37	CCDS14420.1	.	.	.	.	.	.	.	.	.	.	G	21.4	4.139049	0.77775	.	.	ENSG00000147099	ENST00000373573;ENST00000373589;ENST00000429103;ENST00000373568	D;D;D;D	0.82081	-1.57;-1.57;-1.57;-1.57	5.62	5.62	0.85841	Histone deacetylase domain (1);	0.000000	0.85682	D	0.000000	D	0.90338	0.6977	M	0.82323	2.585	0.80722	D	1	D;D;D	0.76494	0.997;0.996;0.999	P;P;P	0.60415	0.703;0.792;0.874	D	0.91271	0.5044	10	0.56958	D	0.05	-14.4908	15.8943	0.79323	0.0:0.0:1.0:0.0	.	243;243;334	B4DKN0;A6NGJ7;Q9BY41	.;.;HDAC8_HUMAN	Y	334;243;139;243	ENSP00000362674:H334Y;ENSP00000362691:H243Y;ENSP00000388459:H139Y;ENSP00000362669:H243Y	ENSP00000362669:H243Y	H	-	1	0	HDAC8	71598584	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	9.367000	0.97148	2.352000	0.79861	0.594000	0.82650	CAT	HDAC8-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000057193.2	67.958183	KEEP		-	70.823025	0.311111	28	62	---	---	---	---	1	0.9999989	51	8	0	102	29	66	0	102	2	0	0	0	0	0	0	29	66	0	102	2	TP
